What SAB Biotherapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 1 | 4 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 473 | 3,437 |
| Net activity | −473 | −3,437 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Kropotova Alexandra | CHIEF MEDICAL OFFICER | Sep 17 | Withheld — tax / exercise cost · F | −473 | — | — | 41,853 |
| Kropotova Alexandra | CHIEF MEDICAL OFFICER | Jun 25 | Withheld — tax / exercise cost · F | −988 | — | — | 42,308 |
| Kropotova Alexandra | CHIEF MEDICAL OFFICER | Mar 24 | Withheld — tax / exercise cost · F | −988 | — | — | 43,296 |
| Kropotova Alexandra | CHIEF MEDICAL OFFICER | Dec 11 | Withheld — tax / exercise cost · F | −988 | — | — | 44,284 |
| Moin Andrew | Director | Sep 29 | Exercise / conversion · M | +1,740,000 | $1.75 | +$3.05M | 2,198,457 |
| Sessa Capital (Master), L.p. | Director | Sep 29 | Exercise / conversion · M | +1,740,000 | $1.75 | +$3.05M | 2,198,457 |
| Kropotova Alexandra | CHIEF MEDICAL OFFICER | Sep 19 | Withheld — tax / exercise cost · F | −1,977 | — | — | 45,272 |
| Kropotova Alexandra | CHIEF MEDICAL OFFICER | Mar 27 | Withheld — tax / exercise cost · F | −1,179 | — | — | 47,249 |
| Kropotova Alexandra | CHIEF MEDICAL OFFICER | Dec 18 | Withheld — tax / exercise cost · F | −9,072 | — | — | 48,428 |
| Sullivan Eddie Joe | Chief Executive Officer | Dec 07 | Open-market buy · P | +1,740 | $0.88 | +$1.53K | 5,232,304 |
| King Michael | CHIEF FINANCIAL OFFICER | Nov 30 | Open-market buy · P | +5,000 | $0.90 | +$4.5K | 5,000 |
| Reich Samuel J | Executive Chairman | Nov 29 | Open-market buy · P | +11,000 | $0.89 | +$9.84K | 219,001 |
| Sessa Capital (Master), L.p. | Director | Nov 24 | Exercise / conversion · M | +4,584,571 | — | — | 4,584,571 |
| Ellias Helen K. | Director | Nov 24 | Exercise / conversion · M | +2,857,142 | — | — | 2,857,142 |
| Moin Andrew | Director | Nov 24 | Exercise / conversion · M | +4,584,571 | — | — | 4,584,571 |
| Kropotova Alexandra | Chief Medical Officer | Mar 14 | Grant / award · A | +275,000 | — | — | 275,000 |
| Spragens Jeffrey G | Director | Dec 07 | Grant / award · A | +82,987 | $1.21 | +$100K | 394,989 |
| Link David Charles | Director | Dec 07 | Grant / award · A | +41,493 | $1.21 | +$50K | 57,313 |
| Hamilton Christine E | Director | Dec 07 | Grant / award · A | +82,987 | $1.21 | +$100K | 3,111,334 |
| Hamilton Christine E | Director | Sep 13 | Open-market buy · P | +10,000 | $0.73 | +$7.3K | 4,993,090 |
Loading...
